References
- Malangu N, Du Plooy WJ, Ogunbanjo GA. Paraffin poisoning in children: What can we do differently? SA Fam Pract 2005, 47(2): 54–56.
- Gibbon CJ. South African Medicines Formulary. Fifth ed. 2000.
References
- Malangu N, Du Plooy WJ, Ogunbanjo GA. Paraffin poisoning in children: What can we do differently? SA Fam Pract 2005, 47(2): 54–56.
References
- Colquhoun I, Brundy S. A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypothesis 1981, 7: 673–679.
- Mitchell EA, Lewis S, Cutler DR. Essential fatty acids and maladjusted behaviour in children. Prostaglandins Leukot med 1983 Nov; 12(3) 281–7.
- Stevens LJ, Zentall SS, Deck JL. Abate ML. Watkins BA, Lipp SR Burgess JR. Essential fatty acid metabolism in boys with attention deficit hyperactivity disorder. Am J Clin Nutr. 1995 Oct; 62(4): 761–8.
- Aman MG, Mitchell EA, Turbot SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J. Abnormal child Psychol 1987; 15 (1); 75–90.
- Arnold LE, Kleykamp D, Votolato N, Taylor WA, Kontras SB, Tobin K. Gamma-linolenic acid for attention-deficit hyperactivity disorder: Placebo-controlled comparison to d-amphetamine. Biol Psychiatry 1989; 25: 222–228.
- Blackburn M. Use of Efamol (oil of evening Primrose) for depression and hyperactivity in children. In: Horrobin DF (ed) Omega-6 Essential Fatty Acids: Pathophysiology and roles in Clinical Medicine. New York. N.Y. Alan R Liss Inc. 1990: 345–349.
- Harding KL, Judah RD, Gant C. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Altern Med. Rev. 2003 Aug; 8(3): 319–30.